ECSP003856A - DOSAGE FORM OF PHARMACO IN LAYERS PROMOTED BY HYDROGEL - Google Patents

DOSAGE FORM OF PHARMACO IN LAYERS PROMOTED BY HYDROGEL

Info

Publication number
ECSP003856A
ECSP003856A ECSP003856A ECSP003856A EC SP003856 A ECSP003856 A EC SP003856A EC SP003856 A ECSP003856 A EC SP003856A EC SP003856 A ECSP003856 A EC SP003856A
Authority
EC
Ecuador
Prior art keywords
drug
core
dosage form
pharmaco
hydrogel
Prior art date
Application number
Other languages
Spanish (es)
Inventor
William John Curatolo
Dwayne Thomas Friesen
Avinash Govind Thombre
Leah Elizabeth Appel
Mark Brian Chidlaw
Ronald Arthur Beyerinck
Kelly L Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003856 priority Critical patent/ECSP003856A/en
Publication of ECSP003856A publication Critical patent/ECSP003856A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Una forma de dosificación de liberación controlada tiene un núcleo recubierto, comprendiendo el núcleo una composición que contiene a un fármaco y una composición hinchable en agua, ocupando cada una regiones separadas en el núcleo. La composición que contiene el fármaco comprende un fármaco de solubilidad baja y un agente que retiene el fármaco. El recubrimiento alrededor del núcleo es permeable al agua e insoluble en agua y tiene por lo menos un orificio de salida. Se describen diversas formulaciones que tienen perfiles específicos de liberación de fármaco.A controlled release dosage form has a coated core, the core comprising a composition containing a drug and a water-swellable composition, each occupying separate regions in the core. The composition containing the drug comprises a drug of low solubility and an agent that retains the drug. The coating around the core is water permeable and insoluble in water and has at least one exit hole. Various formulations having specific drug release profiles are described.

ECSP003856 2000-12-22 2000-12-22 DOSAGE FORM OF PHARMACO IN LAYERS PROMOTED BY HYDROGEL ECSP003856A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003856 ECSP003856A (en) 2000-12-22 2000-12-22 DOSAGE FORM OF PHARMACO IN LAYERS PROMOTED BY HYDROGEL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003856 ECSP003856A (en) 2000-12-22 2000-12-22 DOSAGE FORM OF PHARMACO IN LAYERS PROMOTED BY HYDROGEL

Publications (1)

Publication Number Publication Date
ECSP003856A true ECSP003856A (en) 2001-07-27

Family

ID=42041404

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003856 ECSP003856A (en) 2000-12-22 2000-12-22 DOSAGE FORM OF PHARMACO IN LAYERS PROMOTED BY HYDROGEL

Country Status (1)

Country Link
EC (1) ECSP003856A (en)

Similar Documents

Publication Publication Date Title
CR6656A (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
ECSP034455A (en) DOSAGE FORM OF PHARMACO ACTIVATED BY HYDROGEL
UY27532A1 (en) DOSAGE FORM OF DUAL CONTROLLED RELEASE.
ES2077530B1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS TO CURE TUMOR DISEASES.
UY28509A1 (en) DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS
ES2185816T3 (en) FORMS OF PHARMACEUTICAL DOSAGE FOR THE ORAL ROUTE, WHICH INCLUDE AN INHIBITING AGENT OF THE PUMP OF PROTONS AND A PROCEDURAL AGENT.
CL2004000837A1 (en) INGERIBLE FILM TO ADHER AND DISSOLVE IT IN THE ORAL CAVITY, WHICH INCLUDES A WATER SOLUBLE POLYMER, A SUCRALOSE MASK AND A PHARMACEUTICALLY ACTIVE AGENT.
ES2174073T3 (en) SOLID PHARMACEUTICAL FORM FOR ORAL USE.
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
UY25544A1 (en) NEFAZODONE DOSAGE FORM
AR033418A1 (en) PREPARED DETACHABLE MUCOADHESIVE PHARMACEUTICAL FOR THE ADMINISTRATION OF ACTIVE SUBSTANCE IN VETERINARY AND HUMAN MEDICINE
ES2167061T3 (en) DOSAGE FORMS TO IMPROVE ERECTILE DYSFUNCTION IN MALE SEX PATIENTS.
AR006652A1 (en) PHARMACEUTICAL FORM OF ORAL DOSAGE FOR THE ORAL TREATMENT OF BONE DISEASES.
PT1077680E (en) METHOD OF MANUFACTURE OF A FORM OF ACTIVE AGENT DOSING WITH PROLONGED LIBERATION BANDS
PE20030519A1 (en) DOSAGE FORM, DEVICE AND TREATMENT METHODS
AR032151A1 (en) USE OF AN ANTI-ANGIOGENIC PHARMACO IN CONJUNCTION WITH A PHOTOSENSIBLE AGENT FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE IMPROVED PHOTODYNAMIC TREATMENT OF INDOVATED NEOVASCULATURE
AR010716A1 (en) FORMULATION FOR EFFECTIVE DISINFECTING TABLETS AND METHOD FOR FORMING A DISINFECTING SOLUTION
AR048050A1 (en) MASTICABLE, NON-COMPRESSED, METHODS OF ADMINISTRATION INDIVIDUALLY DOSED
ECSP045110A (en) COMPOSITIONS OF THE PREPARATION CONTAINING A PHYSIOLOGICALLY ACTIVE COMPOSITE OF UNSTABLE ACIDS AND PROCESSES FOR THEIR PRODUCTION
AR032642A1 (en) CHEMOTHERAPICAL COMPOSITIONS OF PACLITAXEL IN MICROEMULSION WITH GREATER ORAL BIODISPONIBILITY.
AR028448A1 (en) FORMULATIONS CONTAINING A GLUCOCORTICOID DRUG FOR THE TREATMENT OF BRONCOPULMONARY DISEASES
AR006892A1 (en) USE OF FORMS OF HYALURONIC ACID (HA) FOR THE TREATMENT OF CANCER
ES2180729T3 (en) THERAPEUTIC COMBINED TREATMENT OF HYPERPROLIFERANT PATHOLOGIES.
UY26171A1 (en) PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF LATE APPEARANCE DYSKINESIA
AR020205A1 (en) STERILIZING EFERVESCENT FORMULATION.